
Nathaniel Herzfeld
Examiner (ID: 2727, Phone: (571)272-5899 , Office: P/3749 )
| Most Active Art Unit | 3762 |
| Art Unit(s) | 3743, 3749, 3762 |
| Total Applications | 626 |
| Issued Applications | 427 |
| Pending Applications | 1 |
| Abandoned Applications | 203 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13925823
[patent_doc_number] => 20190046427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => PEPTIDE HAVING HAIR GROWTH-PROMOTING ACTIVITY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/999744
[patent_app_country] => US
[patent_app_date] => 2017-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5807
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15999744
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/999744 | Peptide having hair growth-promoting activity and use thereof | Feb 8, 2017 | Issued |
Array
(
[id] => 16305332
[patent_doc_number] => 10774110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-15
[patent_title] => Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/073746
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 3918
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073746
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073746 | Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof | Feb 2, 2017 | Issued |
Array
(
[id] => 11864738
[patent_doc_number] => 20170232023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'PEPTIDE-DRUG CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 15/417615
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8538
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15417615
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/417615 | PEPTIDE-DRUG CONJUGATES | Jan 26, 2017 | Abandoned |
Array
(
[id] => 11627601
[patent_doc_number] => 20170137791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS'
[patent_app_type] => utility
[patent_app_number] => 15/413184
[patent_app_country] => US
[patent_app_date] => 2017-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 36966
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15413184
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/413184 | METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS | Jan 22, 2017 | Abandoned |
Array
(
[id] => 11850296
[patent_doc_number] => 20170224788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'C1-INH COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICIENCY'
[patent_app_type] => utility
[patent_app_number] => 15/411744
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5471
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15411744
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/411744 | C1-INH COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICIENCY | Jan 19, 2017 | Abandoned |
Array
(
[id] => 16985481
[patent_doc_number] => 11072637
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-27
[patent_title] => Walnut oligopeptide powder, preparation method and application thereof
[patent_app_type] => utility
[patent_app_number] => 16/071583
[patent_app_country] => US
[patent_app_date] => 2017-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 10503
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071583
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071583 | Walnut oligopeptide powder, preparation method and application thereof | Jan 17, 2017 | Issued |
Array
(
[id] => 17362669
[patent_doc_number] => 11229677
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-25
[patent_title] => Antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition
[patent_app_type] => utility
[patent_app_number] => 16/300566
[patent_app_country] => US
[patent_app_date] => 2017-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 22
[patent_no_of_words] => 6319
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300566
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300566 | Antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition | Jan 8, 2017 | Issued |
Array
(
[id] => 14326565
[patent_doc_number] => 10294286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Chimeric inhibitor molecules of complement activation
[patent_app_type] => utility
[patent_app_number] => 15/400412
[patent_app_country] => US
[patent_app_date] => 2017-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 36867
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15400412
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/400412 | Chimeric inhibitor molecules of complement activation | Jan 5, 2017 | Issued |
Array
(
[id] => 14324181
[patent_doc_number] => 10293083
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Crosslinked peptide hydrogels
[patent_app_type] => utility
[patent_app_number] => 15/398254
[patent_app_country] => US
[patent_app_date] => 2017-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 80
[patent_no_of_words] => 26416
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398254
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/398254 | Crosslinked peptide hydrogels | Jan 3, 2017 | Issued |
Array
(
[id] => 14292005
[patent_doc_number] => 10286111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Crosslinked peptide hydrogels
[patent_app_type] => utility
[patent_app_number] => 15/398412
[patent_app_country] => US
[patent_app_date] => 2017-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 80
[patent_no_of_words] => 26408
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398412
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/398412 | Crosslinked peptide hydrogels | Jan 3, 2017 | Issued |
Array
(
[id] => 14292003
[patent_doc_number] => 10286110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Crosslinked peptide hydrogels
[patent_app_type] => utility
[patent_app_number] => 15/398288
[patent_app_country] => US
[patent_app_date] => 2017-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 80
[patent_no_of_words] => 26405
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398288
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/398288 | Crosslinked peptide hydrogels | Jan 3, 2017 | Issued |
Array
(
[id] => 11713613
[patent_doc_number] => 20170182113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'Crosslinked Peptide Hydrogels'
[patent_app_type] => utility
[patent_app_number] => 15/398379
[patent_app_country] => US
[patent_app_date] => 2017-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 28568
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398379
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/398379 | Crosslinked Peptide Hydrogels | Jan 3, 2017 | Abandoned |
Array
(
[id] => 13761189
[patent_doc_number] => 10172923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Use of endostatin peptides for the treatment of fibrosis
[patent_app_type] => utility
[patent_app_number] => 15/385705
[patent_app_country] => US
[patent_app_date] => 2016-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 34
[patent_no_of_words] => 22693
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15385705
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/385705 | Use of endostatin peptides for the treatment of fibrosis | Dec 19, 2016 | Issued |
Array
(
[id] => 13727983
[patent_doc_number] => 20180368459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => DIETARY PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/062429
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062429
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062429 | Dietary peptides | Dec 15, 2016 | Issued |
Array
(
[id] => 13606889
[patent_doc_number] => 20180354993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => CYCLIC NTCP-TARGETING PEPTIDES AND THEIR USES AS ENTRY INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/780129
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780129
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780129 | Cyclic NTCP-targeting peptides and their uses as entry inhibitors | Dec 14, 2016 | Issued |
Array
(
[id] => 17306302
[patent_doc_number] => 11207385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Melanocortins and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/077710
[patent_app_country] => US
[patent_app_date] => 2016-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 30
[patent_no_of_words] => 24104
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077710
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077710 | Melanocortins and methods of use thereof | Dec 13, 2016 | Issued |
Array
(
[id] => 11663568
[patent_doc_number] => 20170152287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'METHODS AND COMPOSITIONS FOR SITE-SPECIFIC LABELING OF PEPTIDES AND PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/375759
[patent_app_country] => US
[patent_app_date] => 2016-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 33410
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15375759
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/375759 | METHODS AND COMPOSITIONS FOR SITE-SPECIFIC LABELING OF PEPTIDES AND PROTEINS | Dec 11, 2016 | Abandoned |
Array
(
[id] => 16443670
[patent_doc_number] => 10835574
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => Modulators of complement activity
[patent_app_type] => utility
[patent_app_number] => 16/062653
[patent_app_country] => US
[patent_app_date] => 2016-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 30274
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062653
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062653 | Modulators of complement activity | Dec 6, 2016 | Issued |
Array
(
[id] => 13733111
[patent_doc_number] => 20180371023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/060093
[patent_app_country] => US
[patent_app_date] => 2016-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060093
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060093 | Muramyl peptide derivative compound, synthesis and uses thereof | Dec 5, 2016 | Issued |
Array
(
[id] => 16268845
[patent_doc_number] => 20200270332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => Means and Methods for Treating and Diagnosing Fibrosis or Fibrosis-associated Diseases
[patent_app_type] => utility
[patent_app_number] => 15/781028
[patent_app_country] => US
[patent_app_date] => 2016-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15781028
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/781028 | Means and methods for treating and diagnosing fibrosis or fibrosis-associated diseases | Dec 4, 2016 | Issued |